Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica.
Killingley
B
B
Department of Infection and Tropical Medicine, Lister Unit, Northwick Park Hospital, Harrow HA1 3UJ, U.K.
Lamb
L E M
LE
Davidson
R N
RN
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007895:Leishmania tropica; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine